Almark Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 1.00 M
as on 07-07-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 31.87%
(FY 2022)
- Ebitda
- Net Worth -3.13%
(FY 2022)
- Total Assets %
(FY 2022)
About Almark Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Raheel Khan, Nabeel Khan, Saad Memon, and One other member serve as directors at the Company.
- CIN/LLPIN
U36999MH2017PTC289446
- Company No.
289446
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Almark Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saad Memon  | Director | 11-Jan-2017 | Current |
| Raheel Khan | Director | 11-Jan-2017 | Current |
| Nabeel Khan | Director | 11-Jan-2017 | Current |
| Mohammed Patel | Director | 11-Jan-2017 | Current |
Financial Performance of Almark Pharma.
Almark Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 31.87% increase in profit. The company's net worth dipped by a decrease of 3.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Almark Pharma?
In 2019, Almark Pharma had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Edgemark Industries Private LimitedActive 4 years 4 monthsRaheel Khan, Nabeel Khan and 1 more are mutual person
- Brandmark Solutions Private LimitedActive 13 years 9 months
Nabeel Khan and Saad Memon are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Almark Pharma?
Unlock and access historical data on people associated with Almark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Almark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Almark Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
